Clinical TrialsSearch results
Number of results: 220
Other
- Compliance study Medication Event Monitoring System-Utilizing Survey on Bisphosphonate Compliance in Osteoporotic Patients in Japan
- Osteoporotic
- JOCC [Japan Osteoporosis Central-committee for Compliance study]
- 2007-06-30
Other
- A prospective,randomized,single-blind,comparative study of Inslow,palatinose-based liquid formula and Meibalance,standard balanced liquid formula,using viscera fat accumulation as a primary endpoint in adults patients with confirmed diagnosis of obesity and impaired glucose tolerance.
- Obesity and impaired glucose tolerance
- Meiji Dairies Corporation
- 2009-01-01
Recruiting
- MR elastography for early chronic pancreatitis
- Normal, early chronic pancreatitis, chronic pancreatitis
- Tomozawa Yuki
- 2019-01-09
Other
- The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)
- Nonaicoholic fatty liver disease
- Saiseikai Suita Hospital
- 2009-10-01
Other
- A phase II study of Iressa and vinorelbine/gemcitabine in chemo-naive elderly patients with advanced non-small-cell lung cancer screened for EGFR mutation status.
- Non-small-cell lung cancer
- IVAN Investigators
- 2006-06-23
Other
- Single Arm Phase II Trial of Nitroglycerin Plus Docetaxel in Elderly Untreated Stage IIIB/IV Non-small-cell Lung Cancer
- Non-small-cell lung cancer
- Tohoku University Translational Research Center
- 2009-03-31
Other
- Outcome study of complete resections for p-N2 non-small cell lung cancer
- non-small cell lung cancer
- JMTO
- 2008-07-28
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).
- Non small cell lung cancer
- Kyoto Thoracic Oncology Research Group (KTORG)
- 2007-01-01